1. Pitout, J. D., Chan, W. W. & Church, D. L. Tackling antimicrobial resistance in lower urinary tract infections: treatment options. Expert Rev. Anti. Infect. Ther. 24, 1–12 (2016).
2. Monurol package insert. St Louis, MO, Forest Pharmaceuticals, Inc.; (1997)
http://druginserts.com/lib/rx/meds/monurol-1/
.
3. Falagas, M. E., Giannopoulou, K. P., Kokolakis, G. N. & Rafailidis, P. I. Fosfomycin: use beyond urinary tract and gastrointestinal infections. J. Antimicrob. Chemother. 46, 1069–1077 (2008).
4. Walsh, C. C, McIntosh, M. P., Peleg, A. Y., Kirkpatrick, C. M. & Bergen, P. J. In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 70, 3042–3050 (2015).
5. Gómez-Garcés, J. L., Gil-Romero, Y., Sanz-Rodríguez, N., Muñoz-Paraíso, C. & Regodón-Domínguez, M. In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa. Enferm. Infecc. Microbiol. Clin. 34, 228–231 (2016).